A technique for discerning the similarity of DNA specimens supports earlier genetic evidence that Neandertals were a dead-end species, a new study finds. Neandertal DNA exhibits substantial genetic ...

Hologic ($HOLX) will become a major player in molecular diagnostics focused on sexually transmitted diseases and boost its women's health expertise with the company's ...

Background and objectives: The nonisotopic DNA probe assay (PACE 2) was evaluated for the detection of Neisseria gonorrhoeae in urethral and endocervical specimens and compared quantitatively and ...

San Diego-based Gen-Probe has jumped 18 percent on talk that it will be sold, and it may still be worth $1.3 billion more in a takeover by Novartis or Life Technologies, Bloomberg is reporting today.

BRUSSELS, June 3 (Reuters) - U.S. disease diagnosis firm Gen-Probe Inc launched a 215 million euro ($335.4 million) counterbid for Belgian peer Innogenetics NV on Tuesday, trumping an offer from local ...

Gen-Probe Inc. on Monday said the Food and Drug Administration approved its automated system for diagnostic testing for sexually transmitted diseases, sending its stock up 12% to an all-time high. Gen ...

Medical device maker Hologic Inc said it would acquire Gen-Probe Inc for about $3.75 billion in cash to expand its diagnostic business. Under the deal, shareholders of diagnostic test maker Gen-Probe ...

LOS ANGELES, Oct 6 (Reuters) - Gen-Probe Inc said on Tuesday it plans to acquire Prodesse Inc, a privately held provider of clinical tests for influenza and other infectious diseases, for around $60 ...

Bayer, Germany’s second-biggest drug and chemical maker, said it filed counterclaims in an arbitration demanding tens of millions of dollars in damages from Gen-Probe Inc. Bayer’s counterclaims allege ...